Jasper Therapeutics Inc

NASDAQ:JSPR  
7.90
-0.35 (-4.24%)
Earnings Announcements

Jasper Therapeutics Inc - QTRLY Loss Per Share $0.69

Published: 11/12/2021 21:10 GMT
Jasper Therapeutics Inc (JSPR) - Qtrly Loss per Share $0.69.
Q3 Earnings per Share View $-0.28, Revenue View $0.00 -- Refinitiv Ibes Data (analyst estimates).
Further Company Coverage: .
((reuters.
Briefs@thomsonreuters.
Com;)).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.35

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$1.28

More details on our Analysts Page.